• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

选择性20-表维生素D类似物在大鼠骨肉瘤UMR-106细胞中的代谢:1α,25-二羟基-16-烯-20-表维生素D四种新型C-1脂肪酸酯的分离与鉴定

Metabolism of selective 20-epi-vitamin D analogs in rat osteosarcoma UMR-106 cells: Isolation and identification of four novel C-1 fatty acid esters of 1α,25-dihydroxy-16-ene-20-epi-vitamin D.

作者信息

Flarakos Caroline Ceailles, Weiskopf Andrew, Robinson Matthew, Wang Guoshun, Vouros Paul, Sasso Gino J, Uskokovic Milan R, Reddy G Satyanarayana

机构信息

The Barnett Institute and Department of Chemistry and Chemical Biology, Northeastern University, Boston, MA 02115, United States.

Epimer, LLC, 1 Valley View Drive, North Smithfield, RI 02896, United States.

出版信息

Steroids. 2017 Mar;119:18-30. doi: 10.1016/j.steroids.2016.12.013. Epub 2017 Jan 12.

DOI:10.1016/j.steroids.2016.12.013
PMID:28089927
Abstract

Analogs of 1α,25-dihydroxyvitamin D (S1) with 20-epi modification (20-epi analogs) possess unique biological properties. We previously reported that 1α,25-dihydroxy-20-epi-vitamin D (S2), the basic 20-epi analog is metabolized into less polar metabolites (LPMs) in rat osteosarcoma cells (UMR-106) but not in a perfused rat kidney. Furthermore, we also noted that only selective 20-epi analogs are metabolized into LPMs. For example, 1α,25-dihydroxy-16-ene-20-epi-vitamin D (S4), but not 1α,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D (S5) is metabolized into LPMs. In spite of these novel findings, the unequivocal identification of LPMs has not been achieved to date. We report here on a thorough investigation of the metabolism of S4 in UMR-106 cells and isolated two major LPMs produced directly from the substrate S4 itself and two minor LPMs produced from 3-epi-S4, a metabolite of S4 produced through C-3 epimerization pathway. Using GC/MS, ESI-MS and H NMR analysis, we identified all the four LPMs of S4 as 25-hydroxy-16-ene-20-epi-vitamin D-1-stearate and 25-hydroxy-16-ene-20-epi-vitamin D-1-oleate and their respective C-3 epimers. We report here for the first time the elucidation of a novel pathway of metabolism in UMR-106 cells in which both 1α,25(OH)-16-ene-20-epi-D and 1α,25(OH)-16-ene-20-epi-3-epi-D undergo C-1 esterification into stearic and oleic acid esters.

摘要

具有20-表位修饰的1α,25-二羟基维生素D类似物(S1)(20-表位类似物)具有独特的生物学特性。我们之前报道过,基本的20-表位类似物1α,25-二羟基-20-表位维生素D(S2)在大鼠骨肉瘤细胞(UMR-106)中代谢为极性较小的代谢产物(LPMs),但在灌注的大鼠肾脏中则不会。此外,我们还注意到只有选择性的20-表位类似物会代谢为LPMs。例如,1α,25-二羟基-16-烯-20-表位维生素D(S4)会代谢为LPMs,而1α,25-二羟基-16-烯-23-炔-20-表位维生素D(S5)则不会。尽管有这些新发现,但迄今为止尚未明确鉴定出LPMs。我们在此报告了对UMR-106细胞中S4代谢的深入研究,分离出了直接由底物S4本身产生的两种主要LPMs以及由3-表位-S4(通过C-3差向异构化途径产生的S4代谢产物)产生的两种次要LPMs。通过气相色谱/质谱(GC/MS)、电喷雾电离质谱(ESI-MS)和核磁共振氢谱(H NMR)分析,我们将S4的所有四种LPMs鉴定为25-羟基-16-烯-20-表位维生素D-1-硬脂酸酯和-25-羟基-16-烯-20-表位维生素D-1-油酸酯及其各自的C-3差向异构体。我们在此首次报告了UMR-106细胞中一种新的代谢途径的阐明,其中1α,25(OH)-16-烯-20-表位-D和1α,25(OH)-16-烯-20-表位-3-表位-D都会发生C-1酯化生成硬脂酸酯和油酸酯。

相似文献

1
Metabolism of selective 20-epi-vitamin D analogs in rat osteosarcoma UMR-106 cells: Isolation and identification of four novel C-1 fatty acid esters of 1α,25-dihydroxy-16-ene-20-epi-vitamin D.选择性20-表维生素D类似物在大鼠骨肉瘤UMR-106细胞中的代谢:1α,25-二羟基-16-烯-20-表维生素D四种新型C-1脂肪酸酯的分离与鉴定
Steroids. 2017 Mar;119:18-30. doi: 10.1016/j.steroids.2016.12.013. Epub 2017 Jan 12.
2
1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3 and 1alpha,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D3: analogs of 1alpha,25-dihydroxyvitamin D3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway.1α,25 - 二羟基 - 16 - 烯 - 23 - 炔 - 维生素D3和1α,25 - 二羟基 - 16 - 烯 - 23 - 炔 - 20 - 表 - 维生素D3:1α,25 - 二羟基维生素D3的类似物,它们通过C - 24氧化途径抵抗代谢,而是通过C - 3差向异构化途径代谢。
Arch Biochem Biophys. 2000 Nov 15;383(2):197-205. doi: 10.1006/abbi.2000.2074.
3
Tissue specific metabolism of 1alpha,25-dihydroxy-20-epi-vitamin D3 into new metabolites with significant biological activity: studies in rat osteosarcoma cells (UMR 106 and ROS 17/2.8).1α,25-二羟基-20-表维生素D3在组织中的特异性代谢生成具有显著生物活性的新代谢产物:大鼠骨肉瘤细胞(UMR 106和ROS 17/2.8)的研究
J Cell Biochem. 2001;82(4):599-609. doi: 10.1002/jcb.1189.
4
Isolation, identification and biological activity of 24R,25-dihydroxy-3-epi-vitamin D3: a novel metabolite of 24R,25-dihydroxyvitamin D3 produced in rat osteosarcoma cells (UMR 106).24R,25-二羟基-3-表维生素D3的分离、鉴定及生物学活性:一种在大鼠骨肉瘤细胞(UMR 106)中产生的24R,25-二羟基维生素D3的新型代谢产物
J Nutr Sci Vitaminol (Tokyo). 2001 Apr;47(2):108-15. doi: 10.3177/jnsv.47.108.
5
Production of 1alpha,25-dihydroxy-3-epi-vitamin D3 in two rat osteosarcoma cell lines (UMR 106 and ROS 17/2.8): existence of the C-3 epimerization pathway in ROS 17/2.8 cells in which the C-24 oxidation pathway is not expressed.两种大鼠骨肉瘤细胞系(UMR 106和ROS 17/2.8)中1α,25-二羟基-3-表维生素D3的产生:ROS 17/2.8细胞中存在C-3差向异构化途径,而该细胞中不表达C-24氧化途径。
Bone. 1999 May;24(5):457-63. doi: 10.1016/s8756-3282(99)00019-8.
6
C-3 epimerization of vitamin D3 metabolites and further metabolism of C-3 epimers: 25-hydroxyvitamin D3 is metabolized to 3-epi-25-hydroxyvitamin D3 and subsequently metabolized through C-1alpha or C-24 hydroxylation.维生素D3代谢产物的C-3差向异构化及C-3差向异构体的进一步代谢:25-羟基维生素D3代谢为3-表-25-羟基维生素D3,随后通过C-1α或C-24羟基化进行代谢。
J Biol Chem. 2004 Apr 16;279(16):15897-907. doi: 10.1074/jbc.M311473200. Epub 2004 Feb 2.
7
Isolation and identification of 1alpha-hydroxy-3-epi-vitamin D3, a potent suppressor of parathyroid hormone secretion.1α-羟基-3-表维生素D3的分离与鉴定,一种甲状旁腺激素分泌的强效抑制剂。
J Cell Biochem. 2005 Oct 15;96(3):569-78. doi: 10.1002/jcb.20553.
8
Removal of C-ring from the CD-ring skeleton of 1alpha,25-dihydroxyvitamin D3 does not alter its target tissue metabolism significantly.从1α,25 - 二羟基维生素D3的CD环骨架上去除C环不会显著改变其靶组织代谢。
Arch Biochem Biophys. 2007 Apr 15;460(2):254-61. doi: 10.1016/j.abb.2006.11.012. Epub 2006 Nov 21.
9
1alpha,25-dihydroxy-3-epi-vitamin D3: in vivo metabolite of 1alpha,25-dihydroxyvitamin D3 in rats.1α,25 - 二羟基 - 3 - 表维生素D3:大鼠体内1α,25 - 二羟基维生素D3的代谢产物
FEBS Lett. 1999 Apr 9;448(2-3):278-82. doi: 10.1016/s0014-5793(99)00377-4.
10
Enhanced biological activity of 1alpha,25-dihydroxy-20-epi-vitamin D3, the C-20 epimer of 1alpha,25-dihydroxyvitamin D3, is in part due to its metabolism into stable intermediary metabolites with significant biological activity.1α,25-二羟基-20-表维生素D3(1α,25-二羟基维生素D3的C-20差向异构体)生物活性增强,部分原因是其代谢为具有显著生物活性的稳定中间代谢产物。
J Steroid Biochem Mol Biol. 1999 Dec 15;71(3-4):111-21. doi: 10.1016/s0960-0760(99)00130-2.

引用本文的文献

1
Correlation between Prognostic Factors and the Histopathological Response to Neoadjuvant Chemotherapy in Osteosarcoma: A Retrospective Study.骨肉瘤新辅助化疗的预后因素与组织病理学反应的相关性:一项回顾性研究。
Int J Surg Oncol. 2021 Apr 26;2021:8843325. doi: 10.1155/2021/8843325. eCollection 2021.
2
Vitamin D Receptor Signaling and Cancer.维生素 D 受体信号与癌症。
Endocrinol Metab Clin North Am. 2017 Dec;46(4):1009-1038. doi: 10.1016/j.ecl.2017.07.007. Epub 2017 Sep 29.
3
Neoadjuvant chemotherapy combined with limb salvage surgery in patients with limb osteosarcoma of Enneking stage II: a retrospective study.
新辅助化疗联合保肢手术治疗Enneking II期肢体骨肉瘤患者的回顾性研究
Onco Targets Ther. 2017 May 26;10:2745-2750. doi: 10.2147/OTT.S136621. eCollection 2017.